Published in J Thorac Cardiovasc Surg on March 01, 2005
Transbronchial Ablation for Peripheral Lung Cancer | NCT02972177
ENB Guided RFA for Early-stage Peripheral Lung Cancer | NCT03009630
Is radiofrequency ablation or stereotactic ablative radiotherapy the best treatment for radically treatable primary lung cancer unfit for surgery? Interact Cardiovasc Thorac Surg (2012) 1.17
Radiofrequency ablation of lung tumors: imaging features of the postablation zone. Radiographics (2012) 1.04
Image-guided radiofrequency ablation of lung neoplasm in 100 consecutive patients by a thoracic surgical service. Ann Thorac Surg (2009) 1.03
Radiofrequency ablation of medically inoperable stage IA non-small cell lung cancer: are early posttreatment PET findings predictive of treatment outcome? AJR Am J Roentgenol (2011) 0.97
Bronchial thermoplasty: a novel therapy for severe asthma. Clin Chest Med (2013) 0.96
Percutaneous cryoablation for the treatment of medically inoperable stage I non-small cell lung cancer. PLoS One (2012) 0.94
Radiofrequency ablation for early-stage nonsmall cell lung cancer. Biomed Res Int (2014) 0.91
CT-guided percutaneous microwave ablation of pulmonary malignancies: Results in 69 cases. World J Surg Oncol (2012) 0.90
Radiofrequency ablation of lung tumours. Insights Imaging (2011) 0.86
Non-invasive radiofrequency ablation of malignancies mediated by quantum dots, gold nanoparticles and carbon nanotubes. Ther Deliv (2011) 0.86
Comparison of therapeutic results from radiofrequency ablation and stereotactic body radiotherapy in solitary lung tumors measuring 5 cm or smaller. Int J Clin Oncol (2014) 0.86
Thermal ablation of malignant lung tumors. Dtsch Arztebl Int (2013) 0.86
Percutaneous cryoablation of pulmonary metastases from colorectal cancer. PLoS One (2011) 0.85
Radiofrequency ablation for the treatment of pulmonary metastases. Ann Thorac Surg (2009) 0.85
Cryoablation of early-stage primary lung cancer. Biomed Res Int (2014) 0.83
Image-guided radiofrequency ablation for the treatment of early-stage non-small cell lung neoplasm in high-risk patients. Semin Thorac Cardiovasc Surg (2010) 0.82
Primary Treatment Options for High-Risk/Medically Inoperable Early Stage NSCLC Patients. Clin Lung Cancer (2015) 0.80
Radiotherapy and chemotherapy for elderly patients with stage I-II unresected lung cancer. Eur Respir J (2012) 0.79
Computed tomographic features predictive of local recurrence in patients with early stage lung cancer treated with stereotactic body radiation therapy. Clin Imaging (2014) 0.78
Microsimulation model predicts survival benefit of radiofrequency ablation and stereotactic body radiotherapy versus radiotherapy for treating inoperable stage I non-small cell lung cancer. AJR Am J Roentgenol (2013) 0.78
CT-guided radiofrequency ablation for lung cancer. Int J Clin Oncol (2007) 0.77
Radiofrequency ablation in primary non-small cell lung cancer: What a radiologist needs to know. Indian J Radiol Imaging (2016) 0.76
Effect of percutaneous radiofrequency ablation after thoracoscopic pleurodesis for treating non-small cell lung cancer patients with malignant pleural effusion and/or pleural dissemination. Thorac Cancer (2016) 0.75
CT-guided percutaneous cryoablation of central lung tumors. Diagn Interv Radiol (2014) 0.75
Oesophageal carcinoma. Lancet (2013) 5.48
Esophageal sphincter device for gastroesophageal reflux disease. N Engl J Med (2013) 5.41
Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 Trial. J Thorac Cardiovasc Surg (2011) 5.14
Outcomes after minimally invasive esophagectomy: review of over 1000 patients. Ann Surg (2012) 4.70
Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity. Nat Genet (2013) 4.48
Minimally invasive esophagectomy: outcomes in 222 patients. Ann Surg (2003) 4.30
The Pittsburgh Lung Screening Study (PLuSS): outcomes within 3 years of a first computed tomography scan. Am J Respir Crit Care Med (2008) 4.22
Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial. Ann Thorac Surg (2006) 3.76
Technology for automated, rapid, and quantitative PCR or reverse transcription-PCR clinical testing. Clin Chem (2005) 3.42
Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting. Clin Cancer Res (2006) 3.28
Characterization of amplifiable, circulating RNA in plasma and its potential as a tool for cancer diagnostics. Clin Chem (2004) 2.90
MicroRNA expression profiles of esophageal cancer. J Thorac Cardiovasc Surg (2007) 2.85
Egr-1 regulates autophagy in cigarette smoke-induced chronic obstructive pulmonary disease. PLoS One (2008) 2.67
Lung cancer in elderly patients: an analysis of the surveillance, epidemiology, and end results database. J Clin Oncol (2007) 2.57
Systemic chemotherapy for advanced non-small cell lung cancer: recent advances and future directions. Oncologist (2008) 2.53
Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogen. Cancer Res (2002) 2.52
Anatomic segmentectomy in the treatment of stage I non-small cell lung cancer. Ann Thorac Surg (2007) 2.48
Postesophagectomy chylothorax: incidence, risk factors, and outcomes. Ann Thorac Surg (2012) 2.44
First-in-human trial of a STAT3 decoy oligonucleotide in head and neck tumors: implications for cancer therapy. Cancer Discov (2012) 2.31
Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis. Cancer Res (2012) 2.26
Role of polymorphic Fc gamma receptor IIIa and EGFR expression level in cetuximab mediated, NK cell dependent in vitro cytotoxicity of head and neck squamous cell carcinoma cells. Cancer Immunol Immunother (2009) 2.25
Decreased STAT1 expression by promoter methylation in squamous cell carcinogenesis. J Natl Cancer Inst (2006) 2.21
Anatomic segmentectomy for the solitary pulmonary nodule and early-stage lung cancer. Ann Thorac Surg (2012) 2.14
Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis. Ann Thorac Surg (2006) 2.12
Radiofrequency ablation of pulmonary malignant tumors in nonsurgical candidates. J Thorac Cardiovasc Surg (2003) 2.04
Survival after lung volume reduction in chronic obstructive pulmonary disease: insights from small airway pathology. Am J Respir Crit Care Med (2007) 2.04
Durable complete responses with high-dose bolus interleukin-2 in patients with metastatic melanoma who have experienced progression after biochemotherapy. J Clin Oncol (2007) 1.95
Segmental resection spares pulmonary function in patients with stage I lung cancer. Ann Thorac Surg (2004) 1.93
Occult metastases in lymph nodes predict survival in resectable non-small-cell lung cancer: report of the ACOSOG Z0040 trial. J Clin Oncol (2011) 1.93
Minimally invasive operation for esophageal diverticula. Ann Thorac Surg (2005) 1.90
Results of laparoscopic repair of giant paraesophageal hernias: 200 consecutive patients. Ann Thorac Surg (2002) 1.89
Targeting Stat3 abrogates EGFR inhibitor resistance in cancer. Clin Cancer Res (2012) 1.89
SRC family kinases mediate epidermal growth factor receptor ligand cleavage, proliferation, and invasion of head and neck cancer cells. Cancer Res (2004) 1.88
Src kinases mediate STAT growth pathways in squamous cell carcinoma of the head and neck. J Biol Chem (2003) 1.88
Matched-pair and propensity score comparisons of outcomes of patients with clinical stage I non-small cell lung cancer treated with resection or stereotactic radiosurgery. Cancer (2013) 1.83
In vivo antitumor efficacy of STAT3 blockade using a transcription factor decoy approach: implications for cancer therapy. Oncogene (2005) 1.78
Outcomes after a decade of laparoscopic giant paraesophageal hernia repair. J Thorac Cardiovasc Surg (2009) 1.75
STAT3 activation abrogates growth factor dependence and contributes to head and neck squamous cell carcinoma tumor growth in vivo. Cell Growth Differ (2002) 1.69
Esophagectomy for T1 esophageal cancer: outcomes in 100 patients and implications for endoscopic therapy. Ann Thorac Surg (2009) 1.68
Minimally invasive esophagectomy: results of a prospective phase II multicenter trial-the eastern cooperative oncology group (E2202) study. Ann Surg (2015) 1.67
Cetuximab-activated natural killer and dendritic cells collaborate to trigger tumor antigen-specific T-cell immunity in head and neck cancer patients. Clin Cancer Res (2013) 1.63
Combined inhibition of c-Src and epidermal growth factor receptor abrogates growth and invasion of head and neck squamous cell carcinoma. Clin Cancer Res (2008) 1.63
Cervical pharyngostomy: an old technique revisited. Ann Surg (2008) 1.63
Whole genome exon arrays identify differential expression of alternatively spliced, cancer-related genes in lung cancer. Nucleic Acids Res (2008) 1.63
The laparoscopic approach to paraesophageal hernia repair. J Gastrointest Surg (2011) 1.62
Margin and local recurrence after sublobar resection of non-small cell lung cancer. Ann Surg Oncol (2007) 1.60
Resection for esophageal cancer: strategies for optimal management. Ann Thorac Surg (2008) 1.60
Surgical resection should be considered for stage I and II small cell carcinoma of the lung. Ann Thorac Surg (2012) 1.60
Thirty- and ninety-day outcomes after sublobar resection with and without brachytherapy for non-small cell lung cancer: results from a multicenter phase III study. J Thorac Cardiovasc Surg (2011) 1.59
The impact of health insurance status on the survival of patients with head and neck cancer. Cancer (2010) 1.58
Erythropoietin-mediated activation of JAK-STAT signaling contributes to cellular invasion in head and neck squamous cell carcinoma. Oncogene (2005) 1.56
Systematic classification of morbidity and mortality after thoracic surgery. Ann Thorac Surg (2010) 1.52
Hydrogen preconditioning during ex vivo lung perfusion improves the quality of lung grafts in rats. Transplantation (2014) 1.51
Comprehensive genome and transcriptome analysis of the 11q13 amplicon in human oral cancer and synteny to the 7F5 amplicon in murine oral carcinoma. Genes Chromosomes Cancer (2006) 1.49
Downregulation of Dkk3 activates beta-catenin/TCF-4 signaling in lung cancer. Carcinogenesis (2007) 1.46
Feasibility, safety, acceptability, and yield of office-based, screening transnasal esophagoscopy (with video). Gastrointest Endosc (2012) 1.46
Should endobronchial ultrasonography be part of the thoracic surgeon's armamentarium? J Thorac Cardiovasc Surg (2009) 1.45
Revisional surgery after esophagectomy: an analysis of 43 patients. Ann Thorac Surg (2008) 1.44
An extracellular matrix scaffold for esophageal stricture prevention after circumferential EMR. Gastrointest Endosc (2008) 1.43
Vorinostat in solid and hematologic malignancies. J Hematol Oncol (2009) 1.42
Clinical significance of radiologic characterizations in COPD. COPD (2009) 1.41
Contemporaneous management of esophageal perforation. Surgery (2009) 1.41
Comparison of surgical techniques for early-stage thymoma: feasibility of minimally invasive thymectomy and comparison with open resection. J Thorac Cardiovasc Surg (2011) 1.41
Bile exposure inhibits expression of squamous differentiation genes in human esophageal epithelial cells. Ann Surg (2012) 1.40
Anterior minithoracotomy: a direct approach to the difficult hilum for upper lobectomy, pneumonectomy, and sleeve lobectomy. Ann Surg Oncol (2009) 1.38
Endobronchial ultrasound as a diagnostic tool in patients with mediastinal lymphadenopathy. Ann Thorac Surg (2009) 1.37